Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FBLG
FechaHoraFuenteTítuloSímboloCompañía
25/06/202408:31GlobeNewswire Inc.FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
18/06/202415:12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
13/06/202408:31GlobeNewswire Inc.FibroBiologics Set to Join Russell 2000® IndexNASDAQ:FBLGFibroBiologics Inc
06/06/202409:58Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FBLGFibroBiologics Inc
06/06/202408:31GlobeNewswire Inc.FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024NASDAQ:FBLGFibroBiologics Inc
04/06/202413:36Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FBLGFibroBiologics Inc
15/05/202415:30GlobeNewswire Inc.FibroBiologics Announces 2024 Annual Meeting of StockholdersNASDAQ:FBLGFibroBiologics Inc
15/05/202415:02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FBLGFibroBiologics Inc
14/05/202416:24GlobeNewswire Inc.FibroBiologics Files 2024 First Quarter ReportNASDAQ:FBLGFibroBiologics Inc
14/05/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
07/05/202408:31GlobeNewswire Inc.FibroBiologics to Present at the BIO International Convention 2024NASDAQ:FBLGFibroBiologics Inc
25/04/202407:00GlobeNewswire Inc.FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsNASDAQ:FBLGFibroBiologics Inc
11/04/202408:31GlobeNewswire Inc.FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeNASDAQ:FBLGFibroBiologics Inc
04/04/202408:31GlobeNewswire Inc.FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
28/03/202408:31GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusNASDAQ:FBLGFibroBiologics Inc
19/03/202408:31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
13/03/202408:31PR Newswire (US)FibroBiologics to Present at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
06/03/202408:31PR Newswire (US)FibroBiologics Appoints Ruben A. Garcia as General CounselNASDAQ:FBLGFibroBiologics Inc
29/02/202416:44PR Newswire (US)FibroBiologics Files 2023 Form 10-K Annual ReportNASDAQ:FBLGFibroBiologics Inc
20/02/202408:31PR Newswire (US)FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumNASDAQ:FBLGFibroBiologics Inc
13/02/202408:31PR Newswire (US)FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory DiseasesNASDAQ:FBLGFibroBiologics Inc
08/02/202408:31PR Newswire (US)FibroBiologics Announces Three United States Patents for Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
06/02/202408:31PR Newswire (US)FibroBiologics Announces Three Japanese Patents on Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG

Su Consulta Reciente